欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/6310/001
药品名称Azacitidin Seacross 25 mg/ml Pulver zur Herstellung einer Injektionssuspension
活性成分
    • Azacitidine 100.0 mg
剂型Powder for suspension for injection
上市许可持有人Seacross Pharma (Europe) Limited Pod 13 The Old Station House 15a Main Street Blackrock A94 T8P8, Dublin, Ireland
参考成员国 - 产品名称Germany (DE)
Azacitidine 25 mg/ml Pulver und Suspension zur Herstellung einer Injektionssuspension
互认成员国 - 产品名称
    • Denmark (DK)
    • Ireland (IE)
    • Sweden (SE)
    • Norway (NO)
      Azacitidin SUN
    • Latvia (LV)
      Azacitidine Seacross 25 mg/ml pulveris injekciju suspensijas pagatavošanai
    • Lithuania (LT)
      Azacitidine Auxilia 25 mg/ml milteliai injekcinei suspensijai
    • Estonia (EE)
      AZACITIDINE AUXILIA
    • Finland (FI)
许可日期2021/07/06
最近更新日期2025/07/28
药物ATC编码
    • L01BC07 azacitidine
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase